MedDataX Logo

Project IMPACT Immunizations (IMProving America's Communities Together) Scaled Demonstration

NCT ID: NCT03372967

Last Updated: 2019-12-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

6234 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-12-12

Study Completion Date

2019-11-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this study is to evaluate how implementing an innovative care model that provides the pharmacist access to a patient's vaccine history at the point-of-care impacts the pharmacist's ability to identify unmet vaccination needs and increase vaccination rates for routinely recommended adult vaccinations.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This multi-site study will use a pre-post design with a population-based comparison group to investigate the impact of implementing an innovative care model on the pharmacist's ability to identify unmet vaccination needs and increase vaccination rates for routinely recommended adult vaccinations. The innovative care model enables the pharmacist to utilize a bi-directional IIS to assess patients' vaccination histories, identify unmet vaccination needs, and document the care provided. The project duration has been established to allow sufficient time for each pharmacy to implement the innovative care model and monitor each pharmacy for a 6-month study period. The American Pharmacists Association (APhA) Foundation has an a priori intent to publish the project results.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Influenza

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

preventable disease vaccine public health vaccine history point-of-care

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Comprehensive Vaccination History Review

Patients who receive a comprehensive vaccination history review at a participating pharmacy site will be eligible to: a) receive a vaccination forecast review, b) be evaluated for unmet vaccination needs, c) receive patient education, and d) have vaccination needs met.

Vaccine administration by a pharmacist

Intervention Type BIOLOGICAL

Administration, number and types, of vaccines by a pharmacist

Unmet vaccination needs identified and met

Intervention Type BEHAVIORAL

Identification of unmet vaccination needs and having those needs met

Vaccination forecast review and patient education

Intervention Type BEHAVIORAL

Pharmacist review of the vaccination forecast and patient education on his/her vaccine needs

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vaccine administration by a pharmacist

Administration, number and types, of vaccines by a pharmacist

Intervention Type BIOLOGICAL

Unmet vaccination needs identified and met

Identification of unmet vaccination needs and having those needs met

Intervention Type BEHAVIORAL

Vaccination forecast review and patient education

Pharmacist review of the vaccination forecast and patient education on his/her vaccine needs

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals eligible to be enrolled in the study include any person at least 18 years of age who is eligible for a comprehensive vaccination history review as determined by the pharmacist.

Exclusion Criteria

* n/a
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

American Pharmacists Association Foundation

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Benjamin M Bluml, BPharm

Role: PRINCIPAL_INVESTIGATOR

American Pharmacists Association Foundation

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Walmart Pharmacy

Atlantic, Iowa, United States

Site Status

Medicap Pharmacy

Carlisle, Iowa, United States

Site Status

NuCara Pharmacy

Coralville, Iowa, United States

Site Status

Eagle Pharmacy

Eagle Grove, Iowa, United States

Site Status

Medicap Pharmacy

Eldora, Iowa, United States

Site Status

Medicap Pharmacy

Indianola, Iowa, United States

Site Status

Towncrest Pharmacy

Iowa City, Iowa, United States

Site Status

Hy-Vee Pharmacy

Iowa City, Iowa, United States

Site Status

Walmart Pharmacy

Knoxville, Iowa, United States

Site Status

Osterhaus Pharmacy

Maquoketa, Iowa, United States

Site Status

Hy-Vee Pharmacy

Marion, Iowa, United States

Site Status

Walmart Pharmacy

Pella, Iowa, United States

Site Status

NuCara Pharmacy

Pleasant Hill, Iowa, United States

Site Status

NuCara Pharmacy

Traer, Iowa, United States

Site Status

Greenwood Pharmacy

Waterloo, Iowa, United States

Site Status

Meyer Pharmacy

Waverly, Iowa, United States

Site Status

Hy-Vee Pharmacy

West Des Moines, Iowa, United States

Site Status

NuCara Pharmacy

West Union, Iowa, United States

Site Status

Montross Pharmacy

Winterset, Iowa, United States

Site Status

Safeway Pharmacy

Bellevue, Washington, United States

Site Status

Safeway Pharmacy

Issaquah, Washington, United States

Site Status

Albertsons Sav-On Pharmacy

Redmond, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

018

Identifier Type: -

Identifier Source: org_study_id